News

and space exploration company SpaceX (SPACE), welcomed the FDA’s decision shortly after Neuralink announced the designation. “The Blindsight device from Neuralink will enable even those who ...
Neuralink received US FDA approval for the Blindsight chip in September 2024. It was designated as a 'breakthrough device'.
The US Food and Drug Administration (FDA) has awarded a "Breakthrough Device" status to Neuralink’s experimental vision-restoring implant, Blindsight. This designation is intended to fast-track ...